Lupus Nephritis: An Overview of Recent Findings

Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) since it is the major predictor of poor prognosis. In susceptible individuals suffering of SLE, in situ formation and deposit of immune complexes (ICs) from apoptotic bodies occur in the kidneys as a...

Full description

Bibliographic Details
Main Authors: de Zubiria Salgado, Alberto, Herrera-Diaz, Catalina
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318208/
id pubmed-3318208
recordtype oai_dc
spelling pubmed-33182082012-04-25 Lupus Nephritis: An Overview of Recent Findings de Zubiria Salgado, Alberto Herrera-Diaz, Catalina Review Article Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) since it is the major predictor of poor prognosis. In susceptible individuals suffering of SLE, in situ formation and deposit of immune complexes (ICs) from apoptotic bodies occur in the kidneys as a result of an amplified epitope immunological response. IC glomerular deposits generate release of proinflammatory cytokines and cell adhesion molecules causing inflammation. This leads to monocytes and polymorphonuclear cells chemotaxis. Subsequent release of proteases generates endothelial injury and mesangial proliferation. Presence of ICs promotes adaptive immune response and causes dendritic cells to release type I interferon. This induces maturation and activation of infiltrating T cells, and amplification of Th2, Th1 and Th17 lymphocytes. Each of them, amplify B cells and activates macrophages to release more proinflammatory molecules, generating effector cells that cannot be modulated promoting kidney epithelial proliferation and fibrosis. Herein immunopathological findings of LN are reviewed. Hindawi Publishing Corporation 2012 2012-03-22 /pmc/articles/PMC3318208/ /pubmed/22536486 http://dx.doi.org/10.1155/2012/849684 Text en Copyright © 2012 A. de Zubiria Salgado and C. Herrera-Diaz. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author de Zubiria Salgado, Alberto
Herrera-Diaz, Catalina
spellingShingle de Zubiria Salgado, Alberto
Herrera-Diaz, Catalina
Lupus Nephritis: An Overview of Recent Findings
author_facet de Zubiria Salgado, Alberto
Herrera-Diaz, Catalina
author_sort de Zubiria Salgado, Alberto
title Lupus Nephritis: An Overview of Recent Findings
title_short Lupus Nephritis: An Overview of Recent Findings
title_full Lupus Nephritis: An Overview of Recent Findings
title_fullStr Lupus Nephritis: An Overview of Recent Findings
title_full_unstemmed Lupus Nephritis: An Overview of Recent Findings
title_sort lupus nephritis: an overview of recent findings
description Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) since it is the major predictor of poor prognosis. In susceptible individuals suffering of SLE, in situ formation and deposit of immune complexes (ICs) from apoptotic bodies occur in the kidneys as a result of an amplified epitope immunological response. IC glomerular deposits generate release of proinflammatory cytokines and cell adhesion molecules causing inflammation. This leads to monocytes and polymorphonuclear cells chemotaxis. Subsequent release of proteases generates endothelial injury and mesangial proliferation. Presence of ICs promotes adaptive immune response and causes dendritic cells to release type I interferon. This induces maturation and activation of infiltrating T cells, and amplification of Th2, Th1 and Th17 lymphocytes. Each of them, amplify B cells and activates macrophages to release more proinflammatory molecules, generating effector cells that cannot be modulated promoting kidney epithelial proliferation and fibrosis. Herein immunopathological findings of LN are reviewed.
publisher Hindawi Publishing Corporation
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318208/
_version_ 1611518817547059200